NOVEL GRAFT-IMPLANTED MACROPHAGE-TARGETED NANOEMULGELS FOR IN SITU IMMUNOSUPPRESSION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION
$279,325FY2020Defense Health AgencyDOD
Institute For Stem Cell Biology And Regenerative Medicine
Institute For Stem Cell Biology And Regenerative Medicine